Risk of cardiovascular diseases in pyoderma gangrenosum: A population-based study

Eran Shavit^{1

2}, Or Dagan³, Arnon D Cohen^{4

5}, Yuliya Valdman-Grinshpoun^{2

3}, Khalaf Kridin^{6

7}

Affiliations

¹ Dermatology Unit, Barzilai University Medical Center, Ashkelon, Israel.
² The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
³ Department of Dermatology, Soroka University Medical Center, Beer Sheva, Israel.
⁴ Clalit Health Service, Tel Aviv, Israel.
⁵ Faculty of Health Sciences, Siaal Research Center for Family Medicine and Primary Care, Ben-Gurion University of the Negev, Beer Sheba, Israel.
⁶ Azrialy Faculty of Medicine, Bar-Ilan University, Safed, Israel.
⁷ Unit of Dermatology and Skin Research Laboratory, Baruch Padeh Medical Center, Poriya, Israel.

Eran Shavit et al. J Eur Acad Dermatol Venereol. 2023 Feb.

. 2023 Feb;37(2):e197-e199.

doi: 10.1111/jdv.18527. Epub 2022 Aug 24.

Eran Shavit^{1

2}, Or Dagan³, Arnon D Cohen^{4

5}, Yuliya Valdman-Grinshpoun^{2

3}, Khalaf Kridin^{6

7}

¹ Dermatology Unit, Barzilai University Medical Center, Ashkelon, Israel.
² The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba, Israel.
³ Department of Dermatology, Soroka University Medical Center, Beer Sheva, Israel.
⁴ Clalit Health Service, Tel Aviv, Israel.
⁵ Faculty of Health Sciences, Siaal Research Center for Family Medicine and Primary Care, Ben-Gurion University of the Negev, Beer Sheba, Israel.
⁶ Azrialy Faculty of Medicine, Bar-Ilan University, Safed, Israel.
⁷ Unit of Dermatology and Skin Research Laboratory, Baruch Padeh Medical Center, Poriya, Israel.

No abstract available

References

1. Ben Abdallah H, Fogh K, Vestergaard C, Bech R. Pyoderma gangrenosum and interleukin inhibitors: a semi-systematic review. Dermatology. 2021;238(4):785-92. https://doi.org/10.1159/000519320
1. Hadi A, Lebwohl M. Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol. 2011;64(5):950-954.e2. https://doi.org/10.1016/J.JAAD.2010.01.049
1. Ahn C, Negus D, Huang W. Pyoderma gangrenosum: a review of pathogenesis and treatment. Expert Rev Clin Immunol. 2018;14(3):225-33. https://doi.org/10.1080/1744666X.2018.1438269
1. Ashchyan HJ, Butler DC, Nelson CA, et al. JAMA dermatology original investigation the association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatology. 2018;154(4):409-13. https://doi.org/10.1001/jamadermatol.2017.5978
1. Kridin K, Cohen AD, Amber KT. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am J Clin Dermatol. 2018;19(4):479-87. https://doi.org/10.1007/s40257-018-0356-7